161 related articles for article (PubMed ID: 7295437)
1. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
Br Heart J; 1981 Oct; 46(4):404-9. PubMed ID: 7295437
[TBL] [Abstract][Full Text] [Related]
2. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
Curr Med Res Opin; 1983; 8 Suppl 3():38-46. PubMed ID: 6352184
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.
Weidmann P; Beretta-Piccoli C; Meier A; Keusch G; Glück Z; Ziegler WH
Kidney Int; 1983 Feb; 23(2):320-6. PubMed ID: 6341684
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of indapamide in hypertensive patients with or without renal failure. A dose-response curve.
Leenen FH; Smith DL; Farkas RM; Boer WH; Reeves RA; Marquez-Julio A
Am J Med; 1988 Jan; 84(1B):76-85. PubMed ID: 3341390
[TBL] [Abstract][Full Text] [Related]
5. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
Noveck RJ; McMahon FG; Quiros A; Giles T
Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
[TBL] [Abstract][Full Text] [Related]
6. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus.
Weidmann P; Beretta-Piccoli C; Trost BN
Hypertension; 1985; 7(6 Pt 2):II33-42. PubMed ID: 3908320
[TBL] [Abstract][Full Text] [Related]
7. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Shaw S
J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of indapamide in hypertension: neural, renin and metabolic responses.
de Ortiz H; DeQuattro E; Stephanian E; DeQuattro V
Clin Exp Hypertens A; 1983; 5(5):665-72. PubMed ID: 6349866
[TBL] [Abstract][Full Text] [Related]
9. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
Beretta-Piccoli C; Weidmann P
Miner Electrolyte Metab; 1984; 10(5):292-300. PubMed ID: 6387428
[TBL] [Abstract][Full Text] [Related]
10. Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension.
Danielsen H; Pedersen EB; Spencer ES
Br J Clin Pharmacol; 1984 Aug; 18(2):229-31. PubMed ID: 6386023
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
[TBL] [Abstract][Full Text] [Related]
12. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
Bing RF; Russell GI; Swales JD; Thurston H
Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
[TBL] [Abstract][Full Text] [Related]
13. The possible mode of action of indapamide: a review.
Campbell DB
Curr Med Res Opin; 1983; 8 Suppl 3():9-24. PubMed ID: 6352188
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
Schaller MD; Waeber B; Brunner HR
Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
[TBL] [Abstract][Full Text] [Related]
16. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.
Schiffl H; Weidmann P; Beretta-Piccoli C; Cottier C; Seiler AJ; Ziegler WH
Eur J Clin Pharmacol; 1982; 23(3):215-20. PubMed ID: 6756933
[TBL] [Abstract][Full Text] [Related]
18. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
19. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension.
Weidmann P; Beretta-Piccoli C; Link L; Bianchetti MG; Boehringer K; Morton JJ
Hypertension; 1983; 5(6):873-80. PubMed ID: 6360870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
